We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > obstructive sleep apnea

News List

Terason, Anker Biomedical work on diagnosing obstructive sleep apnea biospectrumasia
December 22, 2019
AmCAD®-UO combines artificial intelligence and advanced signal processing with Terason 's ultrasound imaging technology
Therapix Biosciences Announces Interim Results of Phase IIa Study for Obstructive Sleep Apnea americanpharmaceuticalreview
June 20, 2019
Therapix Biosciences announced interim results from its Phase IIa clinical study at Assuta Medical Center in Israel, suggesting that THX-110, a combination of dronabinol (∆-9-tetrahydracannabinol) and CannAmide™ (palmitoylethanolamide, or PEA) ...
Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea drugs
December 24, 2018
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for its new drug application (NDA) for .......
Inspire medical systems upsizes IPO biospectrumasia
May 07, 2018
Inspire Medical Systems has increased the size of its IPO to 6.75M shares (from 5M) priced at $14 - 16.